This is in line with our observations of the clinicopathological analysis using datasets from the GPL570 platform, TCGA, and Kaplan–Meier (Figure 3) that advocated the significant association of the AKR1B10 expression with the disease progression of lung cancer. Here, AKR1B10 is linked to lung carcinoma.